Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 15th International Conference on Clinical and Experimental Dermatology San Antonio, Texas, USA.

Day 2 :

Keynote Forum

Dr. Hima Bindu Gottam

TOLMAR Inc, USA

Keynote: Topical treatment for skin cancer

Time : 09:30-10:10

Conference Series Dermatology 2018 International Conference Keynote Speaker Dr. Hima Bindu Gottam photo
Biography:

Hima Bindu Gottam has completed her Bachelors in Pharmacy at the age of 21 years from Acharya Nagarjuna University, India and M.S. in Chemistry (Thesis) from Western Illinois University, US. She started her career as an Associate Scientist and worked on a variety of dosage forms including oral solutions, transdermal patches, topical dosage forms and parenteral dosage forms. She worked in generic dermatology industry for over 8 years and has more than 18 ANDA approvals in the US within the short span and 8 more products are currently under filing with the agency. She has 2 publications in reputed journals and also completed her Regulatory Affairs Certification (RAC).

Abstract:

Skin cancer is the most common type of cancer in the United States and the incidence of both non-melanoma and melanoma skin cancers continue to increase rapidly despite preventive measures. Early detection of skin cancer symptoms greatly improves the prognosis of patients with any form, in fact, the cure rate for skin cancer is very high if detected early. Hence, it is important to examine the skin regularly to check for new growths or other changes in the skin and any new growths or changes in skin should be treated without delay. Though the differential diagnosis of pigmented lesions is very challenging, the ABCDE rule, self-exams and other multi-point checklists are useful in performing the right diagnosis to the most extent. The deepunderstanding of cancer biology is required not only to diagnose the condition, but also to choose the right treatment. It is not always easy to identify the exact cause of skin cancer in a particular patient, but past medical history information, any history of excessive chemical exposure or past records of sun burns will be able to narrow down the causes for cancer duing case study. The main risk factor for skin cancer is excessive exposure to UV radiation from sunlight, which damages DNA bases and triggers mutations (genetic variations) causing changes in skin cells. Although, the DNA damage is permanant, the skin cancers can still be treatable. The most common treatment options for treating non-melanoma and melanoma skin cancers include surgical excision, chemotherapy, radiation therapy and some non-surgical options including cryosurgery, photodynamic therapy (PDT), topical chemotherapy and etc. These non-surgical options are very safe and effective in treating actinic keratosis and non-melanoma type cancers, in which, the cancer is not spread to lymph nodes or other parts of the body. Of these techniques, PDT is one of newly accepted treatment options for actinic keratoses (AKs) with clearance rates comparable to 5‐flourouracil. The understanding of the biology of this technique has advanced and the technique is considered very efficient, convenient and inexpensive. Also, the PDT has been demonstrated with several potential advantages over surgery and radiotherapy: It is comparatively a non-invasive, has more precise target, repeated doses can be given without limitations unlike radiotherapy and the healing process results are better comparatively. On the other hand, topical chemotherapeutic agent, 5-fluorouracil (FU) has become increasingly accepted since its introduction in early 1960s. The reason is its efficacy, economy and relative absence of
side effects in treating many precancerous conditions and certain benign and malignant tumors. Similarly, Diclofenac, Ingenol mebutate are used as topical gels in treating actinic keratosis and Imiquimod is useful in treating actinic keratosis and some early basal cell cancers.

  • Medical Treatments
Location: San Antonio, Texas
Speaker

Chair

Dr. Daniel De Rossi Fattaccioli

Peru Dermatology Society, Peru

Speaker

Co-Chair

Dr. Somil Singhal

Maharaja Agresen Medical University, India

Session Introduction

Dr. Somil Singhal

Maharaja Agresen Medical University, India

Title: Lab with satellite control & bluetooth set up
Biography:

Dr. Somil Singhal has completed his Bachelor Of Medicine and Surgery ( MBBS) at the age of 25 years of age from Beijing Medical University, China and Post Doctoral Studies in Doctor Of Medicine In Pathology from Ragiv Gandhi University Of Health Sciences, Bangalore, India. Currently he is working as Pathologist in the Haematology Departrment at Maharaja Agresen Group Of Hospitals , NewDelhi, India. He has attended various Conferences, CME’s and published Case studies , Dessertation in reputed journals like IJLSSR, Index Copernicus, Poland Journal Of Dermatology and is the life member of Indian Medical Association and Allahabad Medical Association. Besides this he had worked as a resident in AIIMS Trauma Center in the department of emergency medicine, Cardiac resident at Fortis Hospital Okhla, Delhi and attended various ITO and blood bank camps for service to hthe society.

Abstract:

The World Health Organization (WHO) defines anemia as a hemoglobin <13 g/dl (hematocrit <39%) for adult males and <12 g/dl (hematocrit <36%) for adult non-pregnant females  The most commonly encountered disorders with hypochromic anemia are iron deficiency anemia and beta thalassemia trait. Other disorders to consider includes anemia of chronic disease, lead toxicity and sideroblastic anemia Iron deficiency anaemia is the most common microcytic hypochromic anemia worldwide resulting from lack of sufficient iron to synthesize hemoglobin  Iron deficiency anemia in adults is caused by loss of blood, while in childhood faulty diet is to blame. It is a severe stage of iron shortage in which hemoglobin (or haematocrit) falls below normal range .  Affected individuals show RBC morphological change of microcytosis, hypochromia, anisocytosis and poikilocytosis Beta thalassemia trait (BTT) is an important differential diagnosis of iron deficiency anemia Thalassemia is one of the main autosomal recessive hereditary hemoglobinopathies established within the world population mainly in Mediterranean belt, Far eastern and South East Asian international locations.

Thalassemias are a collection of hemoglobinopathy due to genetic mutations of the hemoglobin (Hb) genes, ensuing in reduced production or total absence of 1 or more globin chains.

Thalassemia includes two main classes, alpha thalassemia and beta thalassemia by the way of their clinical manifestations and genetic background.  Beta thalassemia is the most frequent type of thalassemia which may be categorised in addition into 3 forms: β thalassemia major , β thalassemia intermediate and β thalassemia minor / β thalassemia trait. In developing countries like india where resources are limited, thalassemia is a major health burden. Earlier studies have shown that the overall prevalence of β-thalassemia is 3–4 % with an estimate of around 8,000 to 10,000 new births with major disease each year.  Affected individuals show increased RBC count with morphological change of microcytic hypochromic with no polychromasia and presence of target cells . In the Indian population where the incidence of the beta thalassemia gene is 3-15% depending on the region, it is important to detect the thalassemia carrier and offer genetic counseling and screening of the spouse to prevent the birth of children with beta thalassemia major .Anemia of chronic disorders is a type of anemia associated with a variety of chronic inflammatory, infectious or neoplastic disorders. There is decreased red cells survival, inadequate marrow response, impaired iron mobilization and iron uptake by erythroid cells . The affected individual show RBC morphological change of normocytic normochromic or microcytic hypochromic red cells and the reticulocyte count is decreased. The Sideroblastic Anemia is a refractory anemia with microcytic hypochromic red cells due to a defect in heme synthesis and the inability of mitochondria of developing red cells to incorporate iron into the heme molecule. There is a defect in heme synthesis and the iron transported to the mitochondria gets accumulated. The affected individual shows high degree of anemia with RBC morphological change of marked anisocytosis and poikilocytosis with appearance of microcytes, normocytic normochromic and target cells.Therefore, anemia is adults is a complex problem owing to variations in various haemaological parameters. A complete physical examination should be done in case of anemia as failure to respond to iron therapy means that the person has another cause of anemia. Hence, this neccessity need to take up the study on haematological profile of hypochromic anemia.